MarketPulse

real-world evidence

8 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Omics-Based Clinical Trials Market to Nearly Double to $47.78B by 2030

Omics clinical trials market grows 8.8% annually from $31.71B in 2025 to $47.78B by 2030, driven by personalized medicine demand and AI advances.
PFELLYILMNRHHBYTMO+4personalized medicinereal-world evidence
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

AI Clinical Trial Market Poised to Triple to $8.5B by 2030

AI clinical trial solutions market expanding from $3B to $8.5B by 2030, driven by patient recruitment optimization, cloud platforms, and regulatory automation.
IBMIQVdecentralized clinical trialscloud-based platforms
GlobeNewswire Inc.GlobeNewswire Inc.··Zion Market Research

Life Sciences Consulting Market to Double to $29.6B by 2034 on AI, Drug Complexity

Global life sciences consulting market projected to reach $29.6B by 2034 from $14.1B in 2024, driven by AI adoption and biotech expansion.
ACNregulatory compliancedigital transformation
GlobeNewswire Inc.GlobeNewswire Inc.··Milestone Pharmaceuticals Inc.

Milestone Pharma Launches Real-World Evidence Registry for CARDAMYST Following FDA Approval

Milestone Pharmaceuticals launches RESET-PSVT real-world evidence registry for FDA-approved CARDAMYST nasal spray, enrolling 450 patients across 20 sites beginning end of 2026.
MISTFDA approvalreal-world evidence
GlobeNewswire Inc.GlobeNewswire Inc.··Folia Health

Folia Health and Argenx Partner on Groundbreaking Real-World Evidence Study for CIDP Patients

Folia Health and Argenx launch at-home real-world evidence study capturing CIDP patient symptom data over six months using app-based reporting platform.
ARGXreal-world evidenceCIDP
GlobeNewswire Inc.GlobeNewswire Inc.··Johnson & Johnson

J&J's SPRAVATO Shows Durable Depression Relief in Real-World Study

Johnson & Johnson's SPRAVATO demonstrates sustained effectiveness for treatment-resistant depression in 570-patient European study, with benefits persisting 6 months post-treatment.
JNJtreatment-resistant depressionreal-world evidence
GlobeNewswire Inc.GlobeNewswire Inc.··Senseonics Holdings, Inc.

Senseonics' Eversense 365 Proves Durable: Real-World Data Shows 94% Wear Rate, Strong Glucose Control

Senseonics reports real-world data from 5,059 Eversense 365 CGM users showing 93.8% wear time and strong glucose control metrics over one year.
SENSmedical devicediabetes management
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Clinical Analytics Market Poised to Reach $81.3B by 2030 Amid Digital Health Expansion

Clinical analytics market projected to grow from $33.09B in 2025 to $81.32B by 2030, driven by EHR adoption, AI advances, and value-based care demand.
ORCLORCLpDMDRXUNHCVS+2artificial intelligenceAsia Pacific growth